Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00438399Phase 3Completed
Phase 3, randomised, single-blind trial of clobetasol in psoriasis (6 arms), sponsored by Galderma. Primary endpoint: Percentage of Subjects Preferring Clobetasol Propionate Shampoo Better Than Comparator at 16 weeks. Started Feb 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00438399.